|
HS Code |
378238 |
| Name | Echinacoside |
| Chemical Formula | C35H46O20 |
| Molecular Weight | 786.73 g/mol |
| Appearance | Yellowish brown powder |
| Solubility | Soluble in water and methanol |
| Source | Extracted from Echinacea angustifolia and Cistanche tubulosa |
| Cas Number | 82854-37-3 |
| Purity | Typically ≥98% |
| Storage Conditions | Store in cool, dry place away from light |
| Bioactive Class | Phenylethanoid glycoside |
| Assay Method | HPLC |
As an accredited Echinacoside factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The Echinacoside chemical is packaged in a 10g amber glass bottle with a secure screw cap, labeled with safety and identification information. |
| Shipping | Echinacoside is shipped in secure, airtight containers to protect it from moisture, light, and contamination. Packaging complies with safety and regulatory standards. The shipment is clearly labeled with product information, handling instructions, and hazard warnings. Delivery is expedited to maintain quality, and temperature control is used if required. |
| Storage | Echinacoside should be stored in a tightly sealed container, protected from light, moisture, and air. Store it at -20°C in a dry, cool, and well-ventilated area. Avoid repeated freeze-thaw cycles to maintain stability. Always handle under inert gas if possible to minimize oxidation. Follow safety guidelines and local regulations when storing or handling the compound. |
Competitive Echinacoside prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In the daily business of bulk ingredient manufacturing, certain compounds stand out for their consistency and practical impact. Echinacoside, an active polyphenolic glycoside, draws significant industry attention because of how it bridges bioactivity and formulation options for professionals in pharmaceuticals, nutraceuticals, and skincare fields. Handling this ingredient from raw extraction all the way to finished standardized powders, our focus sits on meeting performance needs for finished product developers who count on batch-to-batch reliability, measurable content, and clear sourcing.
Every day in the plant, our production lines operate with the recognition that Echinacoside’s appeal traces back to its association with herbal roots and scientifically observed actions. Rooted predominantly in Cistanche tubulosa and Echinacea spp., Echinacoside consistently brings value for those seeking botanical solutions with peer-reviewed documentation. Our manufacturing process draws from years of hands-on refinement, filtering, and drying, each step monitored by applications chemists who understand both the technical and commercial stakes.
Over the years, sectors ranging from research labs to large nutrition brands keep requesting two main standardized forms: 8% and 50% pure Echinacoside powders (both with highly controlled moisture content and ultra-low limits on solvent residues). Rather than chasing an elusive “universal grade” label, our team chooses to invest in precision analytics, including HPLC and mass spectrometry, to fix our product line on measurable and replicable results that R&D and procurement departments in pharmaceutical and food companies trust for formulation and further study. The 8% Echinacoside model, mostly used by integrators for wider herbal complex manufacturing, thrives in environments where cost and flexibility are the focus. The 50% specification satisfies institutions with rigorous scientific protocols and requests for potent single-ingredient materials.
Each batch leaves our facility only when we record every critical data point: active content, microbial profile, ash, moisture, and potential heavy metal traces. This isn’t a matter of ticking boxes. Past experience has shown overlooked particle size, batch contamination, or weak traceability brings commercial risk and undermines client confidence. Instead of trusting a third-party for final quality sign-off, our in-house validation draws from real-time analytics and documented manufacturing records. This tight practical control lies behind our brand reliability.
One of the practical concerns that researchers and buyers send our way deals with how Echinacoside differs from other phenolic compounds in both application reliability and supply regularity. At our facility, side-by-side processing of Echinacoside, Verbascoside, and Salidroside routinely reveals deeper nuances that rarely make it into catalogs or distributor marketing sheets. For one, Echinacoside isolates show higher chemical stability during mid- and high-heat applications compared to Verbascoside, which often struggles with thermal breakdown past 50°C. That matters for food technologists planning for baking or pasteurization. Echinacoside holds up well under thermal and UV conditions found in beverage and topical product manufacturing, and this robustness is not a theoretical claim but derived from specific stress testing during pilot runs for clients in Europe and Japan.
Further, the botanical origin story carries real significance. Our experience with Echinacoside from Cistanche tubulosa exposes a different profile of accompanying actives (polysaccharides, lignans, and supporting chlorogenic acids) than those extracted from Echinacea root. These compositional differences often end up influencing not just the marketing story, but test results after encapsulation or blending. As a manufacturer, these distinctions require us to run full-spectrum finger-printing and maintain isolation lines so the end user knows what goes into their formula either for the regulatory filing or for scientific studies seeking to replicate outcome.
On the ground, securing consistent botanical raw materials sets the baseline for value and product credibility. Each season, our procurement team works directly with contracted growers (mostly in the semi-arid zones of Northwestern China) where Cistanche tubulosa matures with traceable cultivation practices. Growing, harvesting, and curing all get logged with GPS markers and farming protocols that control for over-harvesting and pesticide drift, issues too common in poorly managed supply chains. This is about more than compliance; poor oversight in the field creates extraction inconsistencies that are felt months later in the factory—yield shifts, solvent carryovers, or missed purity targets. Our documented audits, running for almost a decade, have repeatedly shielded our customers from headline-making contamination events and abrupt supply interruptions.
Selecting our Echinacoside, formulators always ask about pesticide residues, potential for hidden allergens, and environmental impact. Each crop destined for extraction undergoes an initial screen for common contaminants—organophosphates, pyrethroids, and organochlorides—pushing us to select only lots showing results well inside published international guidelines. The upshot is batches that clear EU and US standards with a margin of safety that has earned repeat orders from regulatory-conscious multinational brands. This presents a shield against future recalls and test failures.
Working daily alongside R&D colleagues in beverage, dietary supplement, and cosmeceutical industries, our feedback loop has amplified a few key learnings on Echinacoside application. In beverage fortification projects, formulators gravitate toward the standardized 8% powder for its moderate bioactive yield. This lower concentration model disperses rapidly in solution thanks to its high solubility profile and low tendency to foam, which matters during automated filling and pasteurization. Higher-content 50% extracts find their niche in tablet and capsule manufacture, where a smaller dose achieves the desired effect, lowering the need for fillers. Some contract manufacturers push for a mid-grade 25% model, but trade-offs in economic yield and technical stability keep it on the sidelines.
Our QA lab keeps tabs on the pressing issue of carrier agents. Maltodextrin or microcrystalline cellulose often provide bulk and improved flow in lower concentration grades, but higher purity models shift to simple spray-dried matrices with no added excipients by request. Pulling samples off the final product belt, our staff routinely tests not just active content, but flow, dispersibility, and interaction with other micro-ingredients—reporting any negatives back to R&D to tweak process or blending steps if needed. There’s no substitute for handling and observation over months of real-world storage and shipping.
Our adherence to analytical rigor remains central to every kilogram leaving our site. High-Performance Liquid Chromatography (HPLC) gives the only accepted quantitative measurement for Echinacoside content. Spectrophotometry lacks the selectivity, inviting variability from structurally similar compounds such as acteoside. This technical precision prevents confusion in clinical research, where under-dosed or incorrectly labeled ingredients risk invalidating trial results or even harming patient trust.
Beyond the number on a certificate, our in-house laboratory has adopted stability testing protocols for every standardized grade. Accelerated aging on every batch means running 40°C/75%RH studies over six months, revealing any hidden decline in potency or unwanted byproduct formation. Early on, skipping this step cost an overseas partner a major contract and led us to invest heavily in ongoing batch retention and random audit programs. These realities direct our standard-setting—we don’t gamble our customers’ reputation or ROI on short-term savings that fail long-term expectations.
As cross-border shipment becomes routine, understanding how Echinacoside travels through customs and regulatory gates sets apart reliable manufacturing partners from questionable brokers. Classification as a natural extract under most customs codes simplifies European and US entry, but the paperwork carries weight: purity certificates, third-party contamination screens, and botanical origin declarations all must line up for customs clearance and rapid market entry.
Our regulatory team stays on top of evolving market positions—for instance, continuous changes in maximum daily intake recommendations or permitted applications (cosmetic against food, for example) across Asia Pacific, the EU, and US. Clients in highly regulated markets need correct and detailed plant sourcing records, a full breakdown of extraction solvents and reagents, and validated microbial certificates that prove compliance. More than once, a rushed import attempted without proper paperwork has led to blocked deliveries or expensive reprocessing, so we invest ahead of new regulatory “asks” by tracking every applied standard in real time.
Much of the market narrative about botanical extracts comes inflated from glossy brochures and copy-pasted claims. As a manufacturer processing multiple metric tons of Echinacoside every year, we see the difference that runs deeper than ad speak. Clients’ success hinges on raw facts—content measured in mg/g alongside clear logging of batch origin, solvent levels, and stability. Our plant design, built from lessons learned with missed yields or complex clearances, empowers us to deliver results that actually hold up under commercial and scientific scrutiny.
Even as new plant sources or extraction “breakthroughs” grab headlines, we pay close attention to the real-world factors limiting scale and reliability. Solvent management frequently sits at the core: lower-grade facilities chasing yield may cut corners with solvent-recycling steps or push through higher impurity loads—a practice that threatens downstream compliance and end-product taste or odor. Our response involves integrating closed-loop evaporation and recapture systems, with online sensors ensuring no off-purity product keylogs make it past the final filter run.
Supply chain stability brings its own hurdles. Severe weather, field blight, or shifting land management policies can suddenly squeeze harvests, with ripple effects showing up months later in price or impurity profiles. Years of hands-on field supervision and pre-purchase contracting give us a buffer—empowering clients to ride out environmental shifts without facing unwelcome surprises on spec or availability.
Market transitions, such as the rise in organic and residue-free food trends, have challenged us to push pesticide testing panels wider, at added cost but genuine benefit for buyers—especially those working with baby food, prenatal supplements, or luxury skincare. As one of the few manufacturers not outsourcing the last stages of cleaning or drying, we control the critical “last mile” of batch quality, avoiding last-minute failures that often trace back to third-party toll operators.
Engagement with clients does not end with a signed order. Over the years we have learned hands-on the many “invisible” factors that support product development, commercial launches, and end-user satisfaction.
Learning from customer feedback has led us to retool our blending equipment, fine-tune our dryer cycles, and re-source packaging components. Each of these changes, borne from project-based critique, has honed a line of Echinacoside suitable for both large-scale contract manufacture and lower-volume specialty production.
Scientific studies consistently highlight Echinacoside for antioxidant, neuroprotective, and tonifying properties. Many clinical pilots explore Echinacoside as a potential agent for cognitive support or cellular resilience, drawing on a pool of peer-reviewed data globally. Our responsibility as a manufacturer lies in bridging these promising leads with the real capabilities—and limits—of the commercial extracts we supply. The active content marked on our specification sheet matches the level validated in published literature, supporting both finished product claims (of those who comply with regulations) and transparent customer communication.
Still, as a direct processor, we find exaggerated or unsupported statements about “miracle” benefits not only misleading but risky, fostering disillusionment when results fail to meet expectations. Both regulatory authorities and discerning buyers increasingly demand data-backed clarity, asking manufacturers like us to present activity data, clinical results, and traceability as table stakes, not marketing afterthoughts.
By declining to overstate unsupported “superfood” claims or short-sell side effects and dose-response relationships, we contribute, in our role, to a responsible industry that rewards fact-based innovation. Our technical bulletins deliver measured, replicable data—dose ranges, pharmacokinetics, dissolution curves, and batch reproducibility—so partners in research and formulation can design sound products that live up to label description and customer trust.
Society’s demand for cleaner processes, ethical sourcing, and real sustainability motivates us to re-examine waste flows, energy consumption, and emission records each quarter. Processing Echinacoside creates organic waste, and, over time, we have invested in closed-loop water recovery and composting of extraction residues at nearby farms. Full compliance with wastewater and emissions standards protects not just our cross-border buyers but our home communities. Energy usage audits emphasize the shift toward renewable sources and smarter energy recovery from thermal steps in our dryers.
Projects seeking solventless extraction techniques, while not always feasible for high-yield industrial production, drive us to experiment in collaboration with academic groups and emerging technology providers. Even small upticks in yield or modest drops in solvent consumption, repeated over multiple tons of annual throughput, translate to less environmental load and more efficient output—an ongoing pursuit.
Innovation also means listening to future needs. Whether driven by changing regulatory frameworks, emerging scientific findings on bioactivity, or new product delivery systems (liquid shots, nanoemulsions, or novel encapsulated blends), a resilient supplier adapts processes and retools manufacturing lines accordingly. We keep research allocation open for field-to-factory traceability, real-time process monitoring upgrades, and next-generation sensors that maximize both output and environmental stewardship.
Years in the trenches as a direct Echinacoside producer have built a foundation of practical, fact-driven understanding—valuable for developers who look beyond glossy claims toward ingredients with reproducible performance, robust traceability, and open communication.
Each kilo of Echinacoside leaving our plant is the result of patient cultivation, meticulous analytics, strategic investment in traceability, and a firm line against compromise. We constantly refine our approach—responding not just to market shifts but to the challenges and feedback that come from those who build, blend, and study these extracts worldwide. Our batch records, regulatory filings, and technical teams reflect a commitment to putting science, safety, and efficiency first—so that finished products bearing our ingredients continue to meet the standards and claims that the industry, and its customers, have come to expect.